206 related articles for article (PubMed ID: 38745011)
1. Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results.
Sevigny J; Uspenskaya O; Heckman LD; Wong LC; Hatch DA; Tewari A; Vandenberghe R; Irwin DJ; Saracino D; Le Ber I; Ahmed R; Rohrer JD; Boxer AL; Boland S; Sheehan P; Brandes A; Burstein SR; Shykind BM; Kamalakaran S; Daniels CW; David Litwack E; Mahoney E; Velaga J; McNamara I; Sondergaard P; Sajjad SA; Kobayashi YM; Abeliovich A; Hefti F
Nat Med; 2024 May; 30(5):1406-1415. PubMed ID: 38745011
[TBL] [Abstract][Full Text] [Related]
2. Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency: A Randomized Clinical Trial.
Ljubenkov PA; Edwards L; Iaccarino L; La Joie R; Rojas JC; Koestler M; Harris B; Boeve BF; Borroni B; van Swieten JC; Grossman M; Pasquier F; Frisoni GB; Mummery CJ; Vandenberghe R; Le Ber I; Hannequin D; McGinnis SM; Auriacombe S; Onofrj M; Goodman IJ; Riordan HJ; Wisniewski G; Hesterman J; Marek K; Haynes BA; Patzke H; Koenig G; Hilt D; Moebius H; Boxer AL
JAMA Netw Open; 2021 Sep; 4(9):e2125584. PubMed ID: 34559230
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus serotype 1-based gene therapy for FTD caused by GRN mutations.
Hinderer C; Miller R; Dyer C; Johansson J; Bell P; Buza E; Wilson JM
Ann Clin Transl Neurol; 2020 Oct; 7(10):1843-1853. PubMed ID: 32937039
[TBL] [Abstract][Full Text] [Related]
4. Restoring neuronal progranulin reverses deficits in a mouse model of frontotemporal dementia.
Arrant AE; Filiano AJ; Unger DE; Young AH; Roberson ED
Brain; 2017 May; 140(5):1447-1465. PubMed ID: 28379303
[TBL] [Abstract][Full Text] [Related]
5. Progranulin Gene Therapy Improves Lysosomal Dysfunction and Microglial Pathology Associated with Frontotemporal Dementia and Neuronal Ceroid Lipofuscinosis.
Arrant AE; Onyilo VC; Unger DE; Roberson ED
J Neurosci; 2018 Feb; 38(9):2341-2358. PubMed ID: 29378861
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia.
Wilke C; Gillardon F; Deuschle C; Hobert MA; Jansen IE; Metzger FG; Heutink P; Gasser T; Maetzler W; Blauwendraat C; Synofzik M
Neurodegener Dis; 2017; 17(2-3):83-88. PubMed ID: 27760429
[TBL] [Abstract][Full Text] [Related]
7. Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations.
Arrant AE; Roth JR; Boyle NR; Kashyap SN; Hoffmann MQ; Murchison CF; Ramos EM; Nana AL; Spina S; Grinberg LT; Miller BL; Seeley WW; Roberson ED
Acta Neuropathol Commun; 2019 Dec; 7(1):218. PubMed ID: 31870439
[TBL] [Abstract][Full Text] [Related]
8. AAV-Mediated Progranulin Delivery to a Mouse Model of Progranulin Deficiency Causes T Cell-Mediated Toxicity.
Amado DA; Rieders JM; Diatta F; Hernandez-Con P; Singer A; Mak JT; Zhang J; Lancaster E; Davidson BL; Chen-Plotkin AS
Mol Ther; 2019 Feb; 27(2):465-478. PubMed ID: 30559071
[TBL] [Abstract][Full Text] [Related]
9. Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations.
Huang M; Modeste E; Dammer E; Merino P; Taylor G; Duong DM; Deng Q; Holler CJ; Gearing M; Dickson D; Seyfried NT; Kukar T
Acta Neuropathol Commun; 2020 Oct; 8(1):163. PubMed ID: 33028409
[TBL] [Abstract][Full Text] [Related]
10. A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy.
Sassi C; Capozzo R; Gibbs R; Crews C; Zecca C; Arcuti S; Copetti M; Barulli MR; Brescia V; Singleton AB; Logroscino G
J Alzheimers Dis; 2016 May; 53(2):475-85. PubMed ID: 27258413
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
Woollacott IOC; Nicholas JM; Heller C; Foiani MS; Moore KM; Russell LL; Paterson RW; Keshavan A; Schott JM; Warren JD; Heslegrave A; Zetterberg H; Rohrer JD
Dement Geriatr Cogn Disord; 2020; 49(1):56-76. PubMed ID: 32344399
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations.
Kashyap SN; Boyle NR; Roberson ED
Neurotherapeutics; 2023 Jan; 20(1):140-153. PubMed ID: 36781744
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of frontotemporal dementia-related deficits and neuroinflammation in progranulin haploinsufficient mice.
Filiano AJ; Martens LH; Young AH; Warmus BA; Zhou P; Diaz-Ramirez G; Jiao J; Zhang Z; Huang EJ; Gao FB; Farese RV; Roberson ED
J Neurosci; 2013 Mar; 33(12):5352-61. PubMed ID: 23516300
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory molecules in Frontotemporal Dementia: cerebrospinal fluid signature of progranulin mutation carriers.
Galimberti D; Bonsi R; Fenoglio C; Serpente M; Cioffi SM; Fumagalli G; Arighi A; Ghezzi L; Arcaro M; Mercurio M; Rotondo E; Scarpini E
Brain Behav Immun; 2015 Oct; 49():182-7. PubMed ID: 26021560
[TBL] [Abstract][Full Text] [Related]
15. Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia.
Holler CJ; Taylor G; McEachin ZT; Deng Q; Watkins WJ; Hudson K; Easley CA; Hu WT; Hales CM; Rossoll W; Bassell GJ; Kukar T
Mol Neurodegener; 2016 Jun; 11(1):46. PubMed ID: 27341800
[TBL] [Abstract][Full Text] [Related]
16. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study.
Sudre CH; Bocchetta M; Heller C; Convery R; Neason M; Moore KM; Cash DM; Thomas DL; Woollacott IOC; Foiani M; Heslegrave A; Shafei R; Greaves C; van Swieten J; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Frisoni GB; Sorbi S; Otto M; Zetterberg H; Ourselin S; Cardoso MJ; Rohrer JD;
Neuroimage Clin; 2019; 24():102077. PubMed ID: 31835286
[TBL] [Abstract][Full Text] [Related]
17. Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants.
Staffaroni AM; Goh SM; Cobigo Y; Ong E; Lee SE; Casaletto KB; Wolf A; Forsberg LK; Ghoshal N; Graff-Radford NR; Grossman M; Heuer HW; Hsiung GR; Kantarci K; Knopman DS; Kremers WK; Mackenzie IR; Miller BL; Pedraza O; Rascovsky K; Tartaglia MC; Wszolek ZK; Kramer JH; Kornak J; Boeve BF; Boxer AL; Rosen HJ;
JAMA Netw Open; 2020 Oct; 3(10):e2022847. PubMed ID: 33112398
[TBL] [Abstract][Full Text] [Related]
18. Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice.
Frew J; Nygaard HB
Acta Neuropathol Commun; 2021 Apr; 9(1):57. PubMed ID: 33795008
[TBL] [Abstract][Full Text] [Related]
19. Human progranulin-expressing mice as a novel tool for the development of progranulin-modulating therapeutics.
Petkau TL; Life B; Lu G; Yang J; Fornes O; Wasserman W; Simpson EM; Leavitt BR
Neurobiol Dis; 2021 Jun; 153():105314. PubMed ID: 33636385
[TBL] [Abstract][Full Text] [Related]
20. Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers.
Alquézar C; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á
J Psychiatry Neurosci; 2016 Jun; 41(4):225-39. PubMed ID: 26624524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
